ICON experts frequently author or contribute to industry trade press. The following are some recent articles.

  • Disruptive Innovation

    Disruptive innovation in the life science industry, based on a panel session hosted by ICON early in 2018 to gather views from senior executives from leading pharma

  • ELITE 2018 Transformational Leader

    An article on Lee Termini's recognition as a ‘transformational leader’ and how he has brought value to market access and reimbursement.

  • Holistic Approach

    Industry survey conducted by ICON in collaboration with ISR Research and Informa's Pharma Intelligence to examine the challenges facing pharma.

  • ICON and DuPage Medical forge clinical research partnership

    The partnership will help expand ICON's access and engagement with investigator sites and patients to reduce overall time and costs that come with drug development.

  • Big Data Drives Drug Development Efforts

    the rise of precision therapies, and big data are the driving forces impacting Contract Research Organizations (CROs)

  • Constant Vigilance

    Discover how safe design and proactive risk management throughout product lifecycles can mitigate medical and financial risks.

  • Using Actigraphy Generated Sleep in Alzheimer's Disease

    The Case for using actigraphy generated sleep and activity endpoints in patients with Alzheimer's disease.

  • Patient-Centric Trial Recruitment

    Challenges of patient recruitment and need for current recruitment methods to evolve, especially for rare diseases & oncology.

  • CRO Trends 2018

    Key development challenges are addressed through big data partnerships, patient recruitment and applied innovation.

  • Bring Your Own Device ePRO

    Insights on patient-centric trials, and how leveraging patients' own devices could enable the collection of patient- reported outcomes (PRO) data.